[1] 程晋. DNA损伤修复及细胞周期检控点激活的研究进展.国际放射医学核医学杂志, 2009, 33(6): 360-364.  doi: 10.3760/cma.j.issn.1673-4114.2009.06.014
[2] 张占春.电离辐射损伤与DNA修复基因.国际放射医学核医学杂志, 2004, 28(1): 26-29.  doi: 10.3760/cma.j.issn.1673-4114.2004.01.010
[3] 杨青山, 樊飞跃. Ku蛋白与DNA修复.国际放射医学核医学杂志, 2008, 32(1): 40-43.  doi: 10.3760/cma.j.issn.1673-4114.2008.01.011
[4] 任振义, 金一尊. Ku蛋白在肿瘤发生中的作用及其靶向抑制策略.国际放射医学核医学杂志, 2008, 32(5): 305-307.  doi: 10.3760/cma.j.issn.1673-4114.2008.05.014
[5] 王芹. X射线修复交叉互补基因功能的研究进展, 国际放射医学核医学杂志, 2005, 29(3): 132-136.  doi: 10.3760/cma.j.issn.1673-4114.2005.03.011
[6] Jorgensen TJ, Helzlsouer KJ, Clipp SC, et al. DNA repair gene variants associated with benign breast disease in high cancer risk women. Cancer Epidemiol Biomarkers Prev, 2009, 18(1): 346-350.
[7] Loizidou MA, Michael T, Neuhausen SL, et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res Treat, 2008, 112(3): 575-579.
[8] Zienolddiny S, Campa D, Lind H, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 2006, 27(3): 560-567.  doi: 10.1093/carcin/bgi232
[9] Yen CY, Liu SY, Chen CH, et al. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med, 2008, 37(5): 271-277.
[10] Moreno V, Gemignani F, Landi S, et al. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res, 2006, 12(7 Pt 1): 2101-2108.
[11] Matullo G, Guarrera S, Sacerdote C, et al. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev, 2005, 14(11 Pt 1): 2569-2578.
[12] Romanowicz-Makowska H, Smolarz B, Zadrozny M, et al. The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Eur J Gynaecol Oncol, 2012, 33(2): 145-150.
[13] Lin WY, Camp NJ, Cannon-Albright LA, et al. A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet, 2011, 48(7): 477-484.  doi: 10.1136/jmedgenet-2011-100018
[14] Yu KD, Chen AX, Qiu LX, et al. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37, 369 subjects. Breast Cancer Res Treat, 2010, 123(1): 219-225.  doi: 10.1007/s10549-010-0753-y
[15] Pooley KA, Baynes C, Driver KE, et al. Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 2008, 17(12): 3482-3489.  doi: 10.1158/1055-9965.EPI-08-0594
[16] Curtin K, Lin WY, George R, et al. Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev, 2009, 18(9): 2476-2484.  doi: 10.1158/1055-9965.EPI-09-0187
[17] Krupa R, Sliwinski T, Wisniewska-Jarosinska M, et al. Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer-a case control study. Mol Biol Rep, 2011, 38(4): 2849-2854.
[18] Jiao L, Hassan MM, Bondy ML, et al. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am J Gastroenterol, 2008, 103(2): 360-367.
[19] Li D, Liu H, Jiao L, et al. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res, 2006, 66(6): 3323-3330.  doi: 10.1158/0008-5472.CAN-05-3032
[20] Wang R, Wang W, Zhang JW. Correlation between XRCC2 and XRCC5 single nucleotide polymorphisms and drug-sensitivity of human lung cancer cells. Zhonghua Yi Xue Za Zhi, 2008, 88(43): 3059-3062.
[21] Bastos HN, Antão MR, Silva SN, et al. Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroid cancer risk. Thyroid, 2009, 19(10): 1067-1075.  doi: 10.1089/thy.2009.0099
[22] Webb PM, Hopper JL, Newman B, et al. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev, 2005, 14(2): 319-323.
[23] Jakubowska A, Gronwald J, Menkiszak J, et al. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev, 2007, 16(2): 270-275.
[24] Wiśniewska-Jarosińska M, Sliwińfski T, Krupa R, et al. The role of Rad51 gene polymorphism in patients with colorectal cancer in the Polish subpopulation. Pol Merkur Lekarski, 2009, 26(155): 455-457.